NCT03428984View on ClinicalTrials.gov

Study in Adult Subjects Undergoing Posterolateral Thoracotomy

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 3, 2018

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Postoperative Pain Management
Interventions
DRUG

EXPAREL

EXAPREL 266 mg in 20 mL

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY